Showing results (71-80 of 187) with videos related to
Sort By:
Pageof 19
Urologic Oncology|July 22, 2011
Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective studyRaphaële Renard-Penna, Morgan Rouprêt, Eva Comperat, et al.Plos One|January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapiesAlexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.Ultrasound in Medicine & Biology|May 31, 2017
In Vivo Multiparametric Ultrasound Imaging of Structural and Functional Tumor Modifications during TherapyAlexandre Dizeux, Thomas Payen, Delphine Le Guillou-Buffello, et al.Journal of Nephrology|April 26, 2021
More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimensJohannes Philipp Kläger, Ahmad Al-Taleb, Mladen Pavlovic, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Bladder cancer in neurological patients: analysis of a single-centre series]Jérôme Parra, Sarah Drouin, Eva Comperat, et al.European Urology Oncology|January 5, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer PatientsOlivier Cussenot, Kirsten M Timms, Emmanuel Perrot, et al.World Journal of Urology|April 28, 2022
Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institutionLouis Lenfant, Raphaele Renard-Penna, Yann de Rycke, et al.The Canadian Journal of Urology|April 21, 2015
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center studySusanna Cattarino, Thomas Seisen, Sarah J Drouin, et al.World Journal of Urology|October 12, 2012
Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumoursDavid R Yates, Morgan Rouprêt, Sarah J Drouin, et al.World Journal of Urology|June 27, 2008
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancerVincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, et al.Pageof 19